South Africa: Poor management blamed for bulk of drug stock outs

Laura Lopez Gonzalez
May 28, 2015, 9:24 p.m.

Health Minister Dr Aaron Motsoaledi has blamed manufacturers for shortages of medicines including HIV and tuberculosis drugs, but a civil society coalition has alleged 80 percent of stock outs are due to poor management.

According to Motsoaledi, recent reports by Times Live and eNCA regarding alleged widespread drug shortages promoted the minister’s early return last week from the World Health Organisation’s on-going, annual World Health Assembly in Geneva.

At a Pretoria press conference yesterday (May 24), Motsoaledi widespread shortages of drugs including the country’s three-in-one antiretroviral (ARVs) fixed-dose combination (FDC).

“The FDC is our flagship programme and we do everything in our power to protect it,” Motsoaledi said in a statement. “To make sure that there are not problems in this very important programme, we even implemented the practice of a national buffer stock whereby 10 percent of all the FDCs we provide are strategically stockpiled with a service provider in a warehouse.”

Motsoaledi also added that the county source the combination ARV from three different suppliers to guard against supplier problems affecting supply.

“At no stage did we have a shortage of FDC in the country,” he added.

As of September 2015, about 119,000 patients had been started on the FDC.

One in five facilities have experienced stock outs

The department recently released a list of at least 40 medications – including adult and paediatric ARVs, morphine and standard TB treatment – that were running short at provincial depots nationwide. The department attributed the bulk of shortages to supplier constrained and shortages of the pharmaceutical ingredients used to make the drugs.

Comprised of civil groups including Medicines Sans Frontières, the Treatment Action Campaign and the Southern African HIV Clinicians Society, the Stop Stock Outs Project (SSP) collects stock out reports from health workers and clinics nationwide.

The group recently surveyed more than 2,500 of the country’s 3,732 health facilities. According to the research to be presented at the upcoming SA AIDS Conference, one in five facilities reported experiencing an ARV or TB medication stock out.

According to a SSP statement released yesterday, management or logistical challenges between medicine depots and clinics caused 80 percent of stock outs.

However, the group noted that patients were turned away without any medication in only 20 percent of cases.

“Supply of medicine to clinics and hospitals is the basic pillar to any public health system and stock outs of medicines are indicative of a bigger problem related to the management and accountability in a health system,” said SSP’s Dr Karl Le Roux in the statement.

The findings show an improvement over the group’s previous survey in which about one in four facilities reported stock outs.

However, more than 40 percent of health facilities in seven districts reported at least one HIV and TB drug stock outs. These districts include the Eastern Cape’s Joe Gqabi and Alfred Nzo as well as the Free State’s Lejweleputswa and Fezile Dabi districts.


Source: Health-e